Cellectis S.A. DPO 2011-2026 | CLLS

DPO Jährlich Cellectis S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	975	-	-	-	-

Alle Zahlen in USD-Währung

Höchstwert	Mindestwert	Durchschnitt
975	975	975

Name	DPO	Preis	% 24h	Marktkapitalisierung	Land
Alnylam Pharmaceuticals ALNY	55	$ 330.34	3.6 %	$ 43.3 B	USA
CollPlant Biotechnologies Ltd. CLGN	72.6	$ 0.44	-16.64 %	$ 5.04 M	Israel
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Catalyst Pharmaceuticals CPRX	58.1	$ 24.98	1.17 %	$ 3.05 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Cardiff Oncology CRDF	406	$ 1.58	-	$ 106 M	USA
Curis CRIS	3.24 K	$ 0.53	-3.07 %	$ 6.98 M	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Crinetics Pharmaceuticals CRNX	4.83 K	$ 37.7	1.26 %	$ 3.55 B	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Aquestive Therapeutics AQST	395	$ 4.09	-0.97 %	$ 437 M	USA
Daré Bioscience DARE	1.64 K	$ 1.81	4.02 %	$ 20.2 M	USA
DBV Technologies S.A. DBVT	28.6 K	$ 20.36	-3.32 %	$ 2.84 B	France
Dyadic International DYAI	105	$ 0.87	-2.8 %	$ 31.5 M	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	4.06 K	$ 31.37	1.0 %	$ 2.08 B	USA